Cows Milk Protein Allergy (CMPA)

What is CMPA?

Cows milk protein allergy (CMPA) is an immunemediated reaction to the proteins found in cows milk, most commonly casein and whey. It is one of the most frequent food allergies in infants and young children, affecting roughly 23% of infants worldwide.

How the Immune System Reacts

In CMPA the body mistakenly identifies milk proteins as harmful. The immune system produces IgE antibodies (IgEmediated allergy) or triggers a nonIgE cellular response. Either pathway can cause a range of symptoms that appear minutes to several days after exposure.

Typical Symptoms

Symptoms vary by age, type of reaction and severity. Common presentations include:

Skin: hives, eczema flareups, redness, swelling.
Gastrointestinal: vomiting, diarrhea, blood in stool, colic, reflux.
Respiratory: wheeze, coughing, nasal congestion, runny nose.
General: irritability, failure to thrive, poor weight gain.
Severe (rare): anaphylaxis rapid swelling, throat tightness, drop in blood pressure.

Diagnosing CMPA

Diagnosis should be guided by a healthcare professional and typically involves:

Detailed clinical history and symptom diary.
Elimination diet removing all cows milk proteins for 24 weeks.
Rechallenge (oral food challenge) under medical supervision to confirm the reaction.
Allergy testing (skin prick test or specific IgE blood test) to support the diagnosis.

Important: Never start an elimination diet without professional advice, as it can affect nutrition.

Management Strategies

1. Dietary Elimination

The cornerstone of treatment is a strict avoidance of cows milk proteins. Options include:

Breastfed infants: mother eliminates dairy from her diet.
Formulafed infants: use extensively hydrolysed formula (eHF) or aminoacid based formula (AAF) for severe cases.
Older children: dairyfree alternatives such as fortified soy, oat, rice, or plantbased milks, ensuring adequate calcium and vitamin D.

2. Nutritional Support

Because dairy is a major source of calcium, protein and vitamin B12, a dietitian should monitor growth and recommend supplements when needed.

3. Medication for Acute Symptoms

Antihistamines for mild skin or respiratory symptoms.
Bronchodilators for wheeze (as prescribed).
Epinephrine autoinjectors for individuals at risk of anaphylaxis.

4. Introduction of Tolerance

Most children outgrow CMPA by age 35. Under specialist supervision, graded oral immunotherapy or monitored reintroduction may be attempted to assess tolerance.

Living with CMPA Practical Tips

Read labels: look for milk, casein, whey, lactose and milk derivatives.
Crosscontamination: use separate cooking utensils and clean surfaces.
Restaurants: inform staff about the allergy and ask about hidden dairy ingredients.
Travel: carry a letter from your doctor and a supply of safe formula or milkfree foods.
School & daycare: provide a written allergy action plan and ensure staff are trained.

Prognosis

Approximately 80% of children with IgEmediated CMPA become tolerant by age 5. NonIgE (cellmediated) forms also improve, though they may persist longer. Early diagnosis and proper management reduce the risk of complications such as nutritional deficiencies, chronic eczema, or severe anaphylaxis.

When to Seek Immediate Help

If a child shows any signs of anaphylaxisdifficulty breathing, swelling of the face or throat, sudden drop in blood pressure, or loss of consciousnesscall emergency services (911/112) right away and administer epinephrine if prescribed.